Ex vivo T-lymphocyte chemokine receptor phenotypes in patients with chronic Chagas disease

Ex vivo T-lymphocyte chemokine receptor phenotypes in patients with chronic Chagas disease

Abstract INTRODUCTION: Elucidating the molecules involved in the inflammatory process of chronic Chagas disease may allow identification of treatment targets. METHODS: The ex vivo phenotypic expression of chemokine receptors CCR1, CCR3, CCR4, CCR5, CXCR2, CXCR3, CXCR4, and CXCR5 on the CD4+ and...

Full description

Bibliographic Details
Main Authors:	Matheus Barbosa de Miranda, Adriene Siqueira de Melo, Mariana Silva Almeida, Silvia Martins Marinho, Wilson Oliveira Junior, Yara de Miranda Gomes
Format:	Article
Language:	English
Published:	Sociedade Brasileira de Medicina Tropical (SBMT)
Series:	Revista da Sociedade Brasileira de Medicina Tropical
Subjects:	Chronic Chagas disease Cardiomyopathy Chemokine receptors
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0037-86822017000500689&lng=en&tlng=en

Similar Items

Avaliação do papel de quimiocinas e seus receptores na evolução das manifestações clínicas em portadores de doença de Chagas crônica
by: MELO, Adriene Siqueira de
Published: (2016)

Immunological and non-immunological effects of cytokines and chemokines in the pathogenesis of chronic Chagas disease cardiomyopathy
by: Edecio Cunha-Neto, et al.
Published: (2009-07-01)

Intermediate Monocytes and Cytokine Production Associated With Severe Forms of Chagas Disease
by: Sergio Gómez-Olarte, et al.
Published: (2019-07-01)

Short-term therapy with simvastatin reduces inflammatory mediators and heart inflammation during the acute phase of experimental Chagas disease
by: Rafael Rodrigues Silva, et al.
Published: (2012-06-01)

Chronic Trypanosoma cruzi-elicited cardiomyopathy: from the discovery to the proposal of rational therapeutic interventions targeting cell adhesion molecules and chemokine receptors - how to make a dream come true
by: Joseli Lannes-Vieira, et al.
Published: (2009-07-01)

Chagas' disease and Duffy antigen/receptor for chemokine (DARC): a mini-review
by: AP Oliveira, et al.
Published: (2011-01-01)

Chronic Heart Disease after Treatment of Oral Acute Chagas Disease
by: Andrei Fornanciari Antunes, et al.

Ethiological treatment of acute and chronic Chagas' heart disease
by: Abílio Augusto Fragata Filho, et al.

Chagas Disease: Where to now?
by: Louise G. Shewan, et al.
Published: (2016-01-01)

Occurrence of Stroke and Reduced Ejection Fraction in Patients with Chagas Disease
by: Elieusa e Silva Sampaio, et al.

Acometimento cardíaco em Casos de Doença de Chagas Aguda da Amazônia Cardiac involvement in Acute Chagas' Disease Cases in the Amazon region
by: João Marcos Barbosa-Ferreira, et al.
Published: (2010-06-01)

Anatomopathological Aspects of Acute Chagas Myocarditis by Oral Transmission
by: Dilma do Socorro Moraes de Souza, et al.
Published: (2016-07-01)

Chagas Disease: From Discovery to a Worldwide Health Problem
by: Kárita Cláudia Freitas Lidani, et al.
Published: (2019-07-01)

Omega-3 supplementation on inflammatory markers in patients with chronic Chagas cardiomyopathy: a randomized clinical study
by: Paula Simplício da Silva, et al.
Published: (2017-06-01)

Seroepidemiological and clinical study of Chagas' disease in Nicaragua Estudio seroepidemiológico y clínico de la enfermedad de Chagas en Nicaragua
by: Teresa Rivera B, et al.
Published: (1995-06-01)

Assessment of syndecan-4 expression in the hearts of Trypanosoma cruzi-infected mice and human subjects with chronic Chagas disease cardiomyopathy
by: Ticiana Ferreira Larocca, et al.
Published: (2018-12-01)

Mathematical Modelling Support of Myocardial Damage Evolution in Chaga’s Disease
by: Sánchez-de Zambrano, Betsy Mirley, et al.
Published: (2020-10-01)

Serum cytokines in chronic Chagas' disease
by: Ward Laura S., et al.
Published: (1999-01-01)

Comparação do desfecho entre a cardiopatia chagásica e a miocardiopatia dilatada idiopática Comparison of outcome between Chagas cardiomyopathy and idiopathic dilated cardiomyopathy
by: Amanda Pires Barbosa, et al.
Published: (2011-12-01)

Back to the future in Chagas disease: from animal models to patient cohort studies, progress in immunopathogenesis research
by: Julio Scharfstein, et al.
Published: (2009-07-01)

CXCL9 and CXCL10 display an age-dependent profile in Chagas patients: a cohort study of aging in Bambui, Brazil
by: Fernanda Fortes de Araújo, et al.
Published: (2020-05-01)

The BENEFIT trial: testing the hypothesis that trypanocidal therapy is beneficial for patients with chronic Chagas heart disease
by: J Antonio Marin-Neto, et al.
Published: (2009-07-01)

Avaliação do metabolismo dos fosfatos de alta energia em pacientes com doença de Chagas Evaluation of the metabolism of high energy phosphates in patients with Chagas' disease
by: Ana Maria Betim Paes Leme, et al.
Published: (2010-08-01)

Chagas disease: a report of 17 suspected cases in Japan, 2012–2017
by: Kazuo Imai, et al.
Published: (2019-06-01)

Chagas cardiomyopathy associated with serological cure after trypanocidal treatment during childhood
by: Marisa Liliana Fernández, et al.

Immunopathologic studies in myocardial biopsies of patients with Chagas' disease and idiopathic cardiomyopathy
by: Maria de Lourdes Higuchi, et al.
Published: (1986-04-01)

PREDICTIVE FACTORS FOR THE PROGRESSION OF CHRONIC CHAGAS CARDIOMYOPATHY IN PATIENTS WITHOUT LEFT VENTRICULAR DYSFUNCTION
by: Silvana de Araújo SILVA, et al.
Published: (2015-04-01)

An Approach to The Acute Phase of Chagas' Disease: The Continuing Challenge it Presents in the 21(st) Century
by: Dário C. Sobral Filho

Feasibility of a Combined Mobile-Health Electrocardiographic and Rapid Diagnostic Test Screening for Chagas-Related Cardiac Alterations
by: Michele Spinicci, et al.
Published: (2021-09-01)

Evaluation of CD4+CD25+ T lymphocyte response time kinetics in patients with chronic Chagas disease after in vitro stimulation with recombinant Trypanosoma cruzi antigens
by: Suellen Carvalho de Moura Braz, et al.
Published: (2013-05-01)

Evaluation of CD4+CD25+ T lymphocyte response time kinetics in patients with chronic Chagas disease after in vitro stimulation with recombinant Trypanosoma cruzi antigens
by: Suellen Carvalho de Moura Braz, et al.
Published: (2013-10-01)

Chagas cardiomyopathy and serologic testing in a small rural hospital in Chiapas, Mexico Miocardiopatía chagásica y pruebas serológicas de enfermedad de Chagas en un hospital rural pequeño de Chiapas, México
by: Linnea Capps, et al.
Published: (2004-05-01)

WHF IASC Roadmap on Chagas Disease
by: Luis Eduardo Echeverría, et al.
Published: (2020-03-01)

Circulating miRNAs as Potential Biomarkers Associated with Cardiac Remodeling and Fibrosis in Chagas Disease Cardiomyopathy
by: Carolina Kymie Vasques Nonaka, et al.
Published: (2019-08-01)

Chagas disease and systemic autoimmune diseases among Bolivian patients in Switzerland
by: Yves Jackson, et al.
Published: (2018-02-01)

Função do átrio esquerdo na miocardiopatia chagásica Function of the left atrium in the Chagas' cardiomyopathy
by: Maria do Carmo Pereira Nunes, et al.
Published: (2005-06-01)

Chagas disease: morbidity profile in an endemic area of Northeastern Brazil
by: Cléber de Mesquita Andrade, et al.
Published: (2015-12-01)

Chagas disease cardiomyopathy: current concepts of an old disease Cardiomiopatia chagásica: conceitos atuais de doença antiga
by: Angelina M.B. Bilate, et al.
Published: (2008-04-01)

The benefits of using selenium in the treatment of Chagas disease: prevention of right ventricle chamber dilatation and reversion of Trypanosoma cruzi-induced acute and chronic cardiomyopathy in mice
by: Andréa P de Souza, et al.
Published: (2010-09-01)

Current knowledge of Chagas-related heart disease among pediatric cardiologists in the United States
by: Sanchi Malhotra, et al.
Published: (2021-03-01)